CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $193,000 | -24.6% | 40,156 | -8.5% | 0.08% | -24.8% |
| Q3 2020 | $256,000 | -4.8% | 43,886 | +10.1% | 0.10% | -3.8% |
| Q2 2020 | $269,000 | -51.3% | 39,866 | -71.6% | 0.10% | +4.0% |
| Q3 2019 | $552,000 | -6.4% | 140,523 | +254.4% | 0.10% | -6.5% |
| Q2 2019 | $590,000 | +98.7% | 39,651 | +231.6% | 0.11% | +100.0% |
| Q1 2019 | $297,000 | – | 11,957 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |